Medpace Holdings, Inc. (MEDP)

629.32 +12.69 (+2.06%) USD  |  NASDAQ  |  Oct 15, 13:57
More

Medpace Holdings Total Long Term Debt (Quarterly) : 120.10M for June 30, 2026

Total Long Term Debt (Quarterly) Chart

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 120.10M
March 31, 2026 122.26M
December 31, 2025 113.64M
September 30, 2025 119.07M
June 30, 2025 124.95M
March 31, 2025 126.66M
December 31, 2024 126.23M
September 30, 2024 128.28M
June 30, 2024 131.80M
March 31, 2024 136.16M
December 31, 2023 142.12M
September 30, 2023 143.04M
June 30, 2023 139.39M
March 31, 2023 142.69M
December 31, 2022 138.87M
September 30, 2022 139.20M
June 30, 2022 134.98M
March 31, 2022 141.62M
December 31, 2021 130.96M
September 30, 2021 128.21M
June 30, 2021 112.85M
March 31, 2021 114.14M
December 31, 2020 115.14M
Date Value
September 30, 2020 110.67M
June 30, 2020 114.98M
March 31, 2020 51.40M
December 31, 2019 45.21M
September 30, 2019 46.02M
June 30, 2019 43.73M
March 31, 2019 102.02M
December 31, 2018 106.30M
September 30, 2018 138.72M
June 30, 2018 189.09M
March 31, 2018 223.66M
December 31, 2017 248.21M
September 30, 2017 211.72M
June 30, 2017 185.22M
March 31, 2017 188.70M
December 31, 2016 192.17M
September 30, 2016 183.60M
June 30, 2016 393.46M
March 31, 2016 408.31M
December 31, 2015 408.16M
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
IQVIA Holdings, Inc. 16.24B
Avantor, Inc. 3.698B
Champions Oncology, Inc. 10.34M
Personalis, Inc. 31.06M
Adaptive Biotechnologies Corp. 401.68M